{"podcast":{"title":"CNBC's \"Fast Money\"","slug":"cnbc-s-fast-money-385199","podcast_index_feed_id":385199,"rss_url":"https://feeds.simplecast.com/szW8tJ16","website_url":"https://www.cnbc.com","image_url":"https://image.simplecastcdn.com/images/92728f12-3d53-46b8-9a33-60e9b83ad72d/b76dd41f-8a3d-42e9-878f-e9bf9c8d572f/3000x3000/fast-money-podcast-cover-art-3000x3000-v05.jpg?aid=rss_feed","author":"CNBC","episode_count":2136,"summary":"Hosted by Melissa Lee and a roundtable of top traders, “Fast Money” breaks through the noise of the day, to deliver the actionable news that matters most to investors. Fast Money airs weeknights at 5p ET on CNBC. Visit http://fastmoney.cnbc.com for additional information.","last_synced_at":"2026-06-17T10:20:31.392906+00:00","page_url":"https://stenobird.com/podcast/cnbc-s-fast-money-385199"},"episode":{"title":"Intel & Memory Stocks Surge… And Protagonist CEO On Drug Approval 5/5/26","slug":"intel-memory-stocks-surge-and-protagonist-ceo-on-drug-approval-5-5-26","published_at":"2026-05-05T22:35:32+00:00","page_url":"https://stenobird.com/podcast/cnbc-s-fast-money-385199/intel-memory-stocks-surge-and-protagonist-ceo-on-drug-approval-5-5-26","show_page_url":"https://stenobird.com/podcast/cnbc-s-fast-money-385199","url":"https://www.cnbc.com","audio_url":"https://dts.podtrac.com/redirect.mp3/cnbc.simplecastaudio.com/b7b89f33-e5b5-46a6-9e42-7f843e9567e5/episodes/0e56911a-ea52-462c-838f-41d620be02d1/audio/128/default.mp3?aid=rss_feed&awCollectionId=b7b89f33-e5b5-46a6-9e42-7f843e9567e5&awEpisodeId=0e56911a-ea52-462c-838f-41d620be02d1&feed=szW8tJ16","summary":"Semi stocks soaring, as Intel and memory names jump double digits. How much more this trade can climb, and how our traders are positioning in the chip rip. Plus, Meta’s copyright complications, Coinbase cuts heads as AI shakes up the workforce, and the CEO of biopharma company Protagonist on its recent drug approval and the stock’s big run up over the past year. Fast Money Disclaimer","meta_description":"Semi stocks soaring, as Intel and memory names jump double digits. How much more this trade can climb, and how our traders are positioning in the chip rip…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2608,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/cnbc-s-fast-money-385199/episodes/intel-memory-stocks-surge-and-protagonist-ceo-on-drug-approval-5-5-26/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/cnbc-s-fast-money-385199/intel-memory-stocks-surge-and-protagonist-ceo-on-drug-approval-5-5-26.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}